RenovaCare Provides Update On Clinical Trial for the SkinGun™ and CellMist™ System for Wound Healing
Roseland, NJ – July 22, 2021 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today provided an update on its clinical trial evaluating the safety and feasibility of the SkinGun™ and CellMist™ System to facilitate wound healing using skin cells obtained directly from the burn patient.